Department of Medicine

May 29, 2018

New research finds lung cancer risk drops substantially within five years of quitting smoking

Just because you stopped smoking years ago doesn’t mean you’re out of the woods when it comes to developing lung cancer.  That’s the “bad” news. The good news is your risk of lung cancer drops substantially within five years of quitting.

By Bill Snyder
May 23, 2018

Evolution of a deadly virus

Genomic sequences have revealed that Florida is a major source of a mosquito-borne virus that causes disease in horses and humans.

By Leigh MacMillan
May 17, 2018

Park named to VICC breast cancer leadership position

By Doug Campbell
May 10, 2018

Honoring Robertson

David Robertson, MD, second from left, poses with three longtime colleagues who spoke during last week’s symposium honoring his scientific legacy.

By Bill Snyder
May 10, 2018

Grant bolsters kidney cancer immunotherapy research

W. Kimryn Rathmell, MD, PhD, Cornelius Abernathy Craig Professor of Medicine and director of the Division of Hematology and Oncology at Vanderbilt-Ingram Cancer Center (VICC), has received a grant to research the role of immunosuppression in the tumor microenvironment for kidney cancer.

By Doug Campbell
May 7, 2018

Records point to drug-drug interaction

Patients who take a cholesterol-lowering statin drug while taking the antibiotic daptomycin have increased risk of developing muscle weakness or a more severe form of muscle damage.

By Paul Govern
May 4, 2018

New breast cancer targets

A special genetic analysis has revealed candidate genes associated with increased risk of breast cancer.
By Bill Snyder
May 3, 2018

Understanding HDL structure

Structural features of newly formed HDL particles will help guide understanding of “good cholesterol” and its function.
By Leigh MacMillan
May 3, 2018

Six Vanderbilt physicians honored by medical societies

Four faculty members of Vanderbilt University School of Medicine were among 78 physician-scientists inducted into The American Society for Clinical Investigation (ASCI), an elite honor society of physician-scientists from the upper ranks of academic medicine and industry. They are:
By Bill Snyder
May 3, 2018

LEAP Fellowship bolsters Staub’s antimicrobial stewardship research

Infectious Disease fellow Milner Staub, MD, is among the first awardees of the Leadership in Epidemiology, Antimicrobial Stewardship, and Public health (LEAP) Fellowship.
By Kathy Whitney
April 26, 2018

Ware elected VP of clinical investigation society

With last week’s election of Lorraine Ware, MD, as vice president of the American Society for Clinical Investigation (ASCI), two faculty members of the Vanderbilt University School of Medicine are among the current officers of the elite physician-scientist honor society.
By Bill Snyder
April 19, 2018

Former FDA official explores big data’s impact on healthcare

“Big data” can help reverse the alarming decline in life expectancy in the United States — if universities and academic medical centers take the lead, former U.S. Food and Drug Administrator Robert Califf, MD, told a Vanderbilt audience last week.
By Bill Snyder
April 19, 2018

Symposium to honor Robertson’s research contributions

David Robertson, MD, internationally known for his groundbreaking work in defining and treating often-debilitating neurological disorders of blood pressure regulation, will be honored with a two-day symposium May 3-4 at Langford Auditorium.
By Bill Snyder